Filing Details

Accession Number:
0001144204-13-057268
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-10-28 21:51:35
Reporting Period:
2013-10-24
Filing Date:
2013-10-28
Accepted Time:
2013-10-28 21:51:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100397 Advaxis Inc. ADXS Pharmaceutical Preparations (2834) 841521955
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1329154 J Mark Rosenblum 305 College Road East
Princeton NJ 08540
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-10-24 12,000 $4.00 20,196 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrants Acquisiton 2013-10-24 6,000 $0.00 6,000 $5.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,000 2013-10-22 2018-10-22 No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,706 Direct
Footnotes
  1. Represents shares of common stock acquired pursuant to issuer's 2011 Employee Stock Purchase Plan.
  2. Voluntarily purchased with cash portion of transaction bonus.